UConn Health and The Jackson Laboratory for Genomic Medicine have been collaborating on brain tumor genomic sequencing for the last five years. Most recently, they’re employing a methylome profiling technique and using the data it yields to inform treatment decisions.
“We are one of the few centers in the country that can routinely do a 550-gene panel analysis of tumors in almost real-time to guide treatment,” says. Dr. Ketan Bulsara, chief of the UConn Health Division of Neurosurgery.